HUM
41
-4
HRL
35
-3
DD
53
-6
NEM
40
3
GE
61
-3
NWS
75
-4
MUR
44
-3
DNB
74
-6
XOM
42
-6
PBI
56
-2
CRM
60
-7
PCAR
56
-5
DRI
50
-3
OMC
50
-16
DHR
32
-6
RIG
43
-7
BSX
64
-3
CNP
54
10
SE
60
-3
WAT
48
-11
HUM
41
-4
HRL
35
-3
DD
53
-6
NEM
40
3
GE
61
-3
NWS
75
-4
MUR
44
-3
DNB
74
-6
XOM
42
-6
PBI
56
-2
CRM
60
-7
PCAR
56
-5
DRI
50
-3
OMC
50
-16
DHR
32
-6
RIG
43
-7
BSX
64
-3
CNP
54
10
SE
60
-3
WAT
48
-11
Financhill
Back

Aldeyra Therapeutics 10K Form

Sell
30

ALDX
Aldeyra Therapeutics

Last Price:
4.21
Seasonality Move:
5.49%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ALDX News And Ratings

See the #1 stock for the next 7 days that we like better than ALDX

ALDX Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-7.97M
Price / Cash Flow: 0
Annual Sales: $1.43
Price / Book: 2.95

Profitability

EPS (TTM): -0.75000
Net Income (TTM): $-44.8M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Aldeyra Therapeutics Earnings Forecast

Key Aldeyra Therapeutics Financial Ratios

  • The Interest Expense is -5.52% of Operating Income.
  • Per Share Earnings over the last 13 years have been positive in 8 years.

Aldeyra Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ALDX
CUSIP: 01438T
Website: aldeyra.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ALDX Technical Analysis vs Fundamental Analysis

Sell
30
Aldeyra Therapeutics (ALDX) is a Sell

Is Aldeyra Therapeutics a Buy or a Sell?